|
Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers
RECRUITINGSponsored by Beijing Tiantan Hospital
Actively Recruiting
SponsorBeijing Tiantan Hospital
Started2023-07-25
Est. completion2026-12-31
Eligibility
Age15 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07392411
Summary
This research employs AI to analyze facial expressions and speech patterns, aiming to develop new digital tools for diagnosing and differentiating Parkinson's disease and similar disorders.
Eligibility
Age: 15 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Inclusion Criteria for Parkinson's Disease (PD) Group: (1) Diagnostic Criteria: Meet the diagnostic criteria for Parkinson's disease established by the Movement Disorder Society (MDS) in 2015. (2) Age Range: 18-75 years old. (3) Disease Severity: Early-stage PD: Hoehn-Yahr score ≤ 2.5 points. Mid-to-late-stage PD: Hoehn-Yahr score 2.5-5 points. (4) Consent for Data Collection: Willing to undergo facial expression video and speech audio recording. (5) Informed Consent: Signed informed consent form. 2. Inclusion Criteria for Parkinson's Plus Syndromes (MSA-P, PSP) Group: (1) Age Range: 18-75 years old. (2) Diagnostic Criteria: MSA patients must meet the diagnostic criteria established by the \[Chinese Expert Consensus on the Diagnosis of Multiple System Atrophy, 2017\]. PSP patients must meet the diagnostic criteria established by the \[Chinese Clinical Diagnostic Criteria for Progressive Supranuclear Palsy, 2016 Edition\]. (3) Consent for Data Collection: Willing to undergo facial expression video and speech audio recording. (4) Informed Consent: Signed informed consent form. Exclusion Criteria: 1. History of cerebrovascular disease, head trauma, hydrocephalus, brain tumors, or intracranial surgery. 2. Presence of metal implants, cardiac pacemakers, or other metallic foreign bodies (applies to PD patients). 3. Severe dyskinesia in PD patients that would compromise cooperation with video/audio recording. 4. Mini-Mental State Examination (MMSE) score ≤ 24 points.
Conditions4
Healthy ControlMultiple System AtrophyParkinson's DiseaseProgressive Supranuclear Palsy (PSP)
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorBeijing Tiantan Hospital
Started2023-07-25
Est. completion2026-12-31
Eligibility
Age15 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07392411